Knockdown of CypA inhibits interleukin-8 (IL-8) and IL-8-mediated proliferation and tumor growth of glioblastoma cells through down-regulated NF-κB.
Although cyclophilin A (CypA) has been reported to be over-expressed in cancer cells and solid tumors, its expression and role in glioblastomas have not been studied. Herein, we show that expression of CypA in human glioblastoma cell lines and tissues is significantly higher than in normal human astrocytes and normal counterparts of brain tissue. To determine the role of over-expressed CypA in glioblastoma, stable RNA interference (RNAi)-mediated knockdown of CypA (CypA KD) was performed in gliobastoma cell line U87vIII (U87MG · ΔEGFR). CypA KD stable single clones decrease proliferation, infiltration, migration, and anchorage-independent growth in vitro and with slower growth in vivo as xenografts in immunodeficient nude mice. We have also observed that knockdown of CypA inhibits expression of interleukin-8 (IL-8), a tumorigenic and proangiogenic cytokine. Conversely, enforced expression of CypA in the CypA KD cell line, Ud-12, markedly enhanced IL-8 transcripts and restored Ud-12 proliferation, suggesting that CypA-mediated IL-8 production provides a growth advantage to glioblastoma cells. CypA knockdown-mediated inhibition of IL-8 is due to reduced activity of NF-κB, which is one of the major transcription factors regulating IL-8 expression. These results not only establish the relevance of CypA to glioblastoma growth in vitro and in vivo, but also suggest that small interfering RNA-based CypA knockdown could be an effective therapeutic approach against glioblastomas.
Sun
Shan
S
Dental Research Institute, UCLA School of Dentistry, Los Angeles, CA, 90095, USA.
Wang
Qiuwei
Q
Giang
An
A
Cheng
Cong
C
Soo
Chia
C
Wang
Cun-Yu
CY
Liau
Linda M
LM
Chiu
Robert
R
D000818:Animals; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D021984:Cyclophilin A / Q000235:genetics / Q000378:metabolism*; D015536:Down-Regulation; D024202:Electrophoretic Mobility Shift Assay; D004797:Enzyme-Linked Immunosorbent Assay; D005909:Glioblastoma / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D016209:Interleukin-8 / Q000378:metabolism*; D051379:Mice; D008819:Mice, Nude; D016328:NF-kappa B / Q000378:metabolism*; D034622:RNA Interference; D020133:Reverse Transcriptase Polymerase Chain Reaction; D046888:Tissue Array Analysis
D016209:Interleukin-8; D016328:NF-kappa B; D021984:Cyclophilin A
Nat Chem Biol. 2007 Oct;3(10):619-29
17876319
Neurochem Int. 2005 Nov;47(6):430-41
16087277
Lung Cancer. 1997 Oct;18(2):189-98
9316010
Cancer Res. 2004 Dec 15;64(24):9018-26
15604267
J Immunol. 2005 Jul 1;175(1):517-22
15972687
Mol Cell Proteomics. 2008 Oct;7(10):1810-23
18421009
J Exp Med. 2007 Aug 6;204(8):1741-8
17635954
Cancer Res. 2007 Apr 15;67(8):3654-62
17440077
J Biol Chem. 2004 Jun 4;279(23):24414-9
15047706
Arterioscler Thromb Vasc Biol. 2004 Jul;24(7):1186-91
15130913
Rev Physiol Biochem Pharmacol. 2003;148:105-50
12698322
Oncogene. 2009 Aug 6;28(31):2784-95
19503092
Cancer Chemother Pharmacol. 2008 Mar;61(3):459-69
17520256
Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10193-7
8234276
J Cell Biochem. 2008 Aug 1;104(5):1625-35
18320592
Eur Cytokine Netw. 1993 Sep-Oct;4(5):351-8
8117936
Immunity. 2004 Aug;21(2):189-201
15308100
Lung Cancer. 2004 Dec;46(3):313-23
15541816
Nat Cell Biol. 2004 Feb;6(2):97-105
14743216
Cancer Res. 2003 Apr 1;63(7):1652-6
12670919
Brain. 2007 Feb;130(Pt 2):476-89
17107968
Neuro Oncol. 2005 Apr;7(2):122-33
15831231
J Leukoc Biol. 2002 Nov;72(5):847-55
12429706
Oncogene. 2004 Sep 9;23(41):6924-32
15286717
J Biol Chem. 2008 Jan 4;283(1):623-637
17991743
J Neurooncol. 1993 Apr;16(1):25-34
8410139
Biochem Biophys Res Commun. 2002 Mar 8;291(4):1031-7
11866469
J Biol Chem. 1995 Feb 10;270(6):2588-94
7852322
Clin Immunol. 2005 Sep;116(3):217-24
15993649
Science. 1984 Nov 2;226(4674):544-7
6238408
Methods. 2001 Dec;25(4):402-8
11846609
J Immunol. 2005 May 15;174(10):6030-8
15879096
Oncogene. 1999 Feb 18;18(7):1447-56
10050881
Mol Cell Biol. 1993 Aug;13(8):4760-9
7687744
Cancer Res. 2005 Oct 1;65(19):8853-60
16204056
Curr Opin Oncol. 2001 May;13(3):160-6
11307058
Immunology. 1991 Mar;72(3):399-404
2026447